These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8917826)

  • 21. Beneficial effects of a skin tolerance-tested moisturizing cream on the barrier function in experimentally-elicited irritant and allergic contact dermatitis.
    De Paépe K; Hachem JP; Vanpee E; Goossens A; Germaux MA; Lachapelle JM; Lambert J; Matthieu L; Roseeuw D; Suys E; Van Hecke E; Rogiers V
    Contact Dermatitis; 2001 Jun; 44(6):337-43. PubMed ID: 11380543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of barrier creams against sulphur mustard. I. In vitro studies using human skin.
    Chilcott RP; Jenner J; Hotchkiss SA; Rice P
    Skin Pharmacol Appl Skin Physiol; 2002; 15(4):225-35. PubMed ID: 12218284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhancement of percutaneous penetration of aniline and o-toluidine in vitro using skin barrier creams.
    Korinth G; Lüersen L; Schaller KH; Angerer J; Drexler H
    Toxicol In Vitro; 2008 Apr; 22(3):812-8. PubMed ID: 18155878
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative effects of pimecrolimus cream vehicle and three commercially available moisturizers on skin hydration and transepidermal water loss.
    Vergnanini AL; Aoki V; Takaoka R; Madi J
    J Dermatolog Treat; 2010 May; 21(3):126-9. PubMed ID: 20394488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple azo disperse dye sensitization mainly due to group sensitizations to azo dyes.
    Nakagawa M; Kawai K; Kawai K
    Contact Dermatitis; 1996 Jan; 34(1):6-11. PubMed ID: 8789217
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of skin barrier creams (IV). The repetitive irritation test (RIT) with a set of 4 standard irritants.
    Frosch PJ; Kurte A
    Contact Dermatitis; 1994 Sep; 31(3):161-8. PubMed ID: 7821009
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of different moisturizers on SLS-irritated human skin.
    Held E; Lund H; Agner T
    Contact Dermatitis; 2001 Apr; 44(4):229-34. PubMed ID: 11260239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cross reaction between Disperse blue dyes 106 and 124.
    Menezes Brandão F; Hausen BM
    Contact Dermatitis; 1987 May; 16(5):289-90. PubMed ID: 3621933
    [No Abstract]   [Full Text] [Related]  

  • 29. After-work emollient creams: effects on irritant skin reactions.
    Blanken R; van der Valk PG; Nater JP; Dijkstra H
    Derm Beruf Umwelt; 1987; 35(3):95-8. PubMed ID: 3608827
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Probing the effectiveness of barrier creams against human skin penetration of nickel powder.
    Magnano GC; Marussi G; Crosera M; Hasa D; Adami G; Lionetti N; Larese Filon F
    Int J Cosmet Sci; 2024 Feb; 46(1):39-50. PubMed ID: 37565324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hydrogel-based ultra-moisturizing cream formulation for skin hydration and enhanced dermal drug delivery.
    Lee SG; Kim SR; Cho HI; Kang MH; Yeom DW; Lee SH; Lee S; Choi YW
    Biol Pharm Bull; 2014; 37(10):1674-82. PubMed ID: 25273390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protective creams fail to prevent solvent-induced cumulative skin irritation - results of a randomized double-blind study.
    Schliemann S; Kleesz P; Elsner P
    Contact Dermatitis; 2013 Dec; 69(6):363-71. PubMed ID: 23844768
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro evaluation of the efficacy of skin barrier creams and protective gloves on percutaneous absorption of industrial solvents.
    Korinth G; Geh S; Schaller KH; Drexler H
    Int Arch Occup Environ Health; 2003 Jun; 76(5):382-6. PubMed ID: 12739171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preventing irritant contact dermatitis with protective creams: influence of the application dose.
    Schliemann S; Petri M; Elsner P
    Contact Dermatitis; 2014 Jan; 70(1):19-26. PubMed ID: 23844826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of Aqueous Cream BP on human stratum corneum in vivo.
    Tsang M; Guy RH
    Br J Dermatol; 2010 Nov; 163(5):954-8. PubMed ID: 20649794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical efficacy evaluation of a novel barrier protection cream.
    Slade HB; Fowler J; Draelos ZD; Reece BT; Cargill DI
    Cutis; 2008 Oct; 82(4 Suppl):21-8. PubMed ID: 19202673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A double-blind comparison of two creams containing urea as the active ingredient. Assessment of efficacy and side-effects by non-invasive techniques and a clinical scoring scheme.
    Serup J
    Acta Derm Venereol Suppl (Stockh); 1992; 177():34-43. PubMed ID: 1466184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Percutaneous penetration (dermatopharmacokinetics) in evaluating barrier creams.
    Zhai H; Maibach HI
    Curr Probl Dermatol; 1996; 25():193-205. PubMed ID: 8787603
    [No Abstract]   [Full Text] [Related]  

  • 39. Dermatitis from an azo-dye in industrial leather protective shoes.
    Ancona A; Serviere L; Trejo A; Monroy F
    Contact Dermatitis; 1982 May; 8(3):220-1. PubMed ID: 7094583
    [No Abstract]   [Full Text] [Related]  

  • 40. The effect of 4 barrier creams on the absorption of water, benzene, and formaldehyde into excised human skin.
    Lodén M
    Contact Dermatitis; 1986 May; 14(5):292-6. PubMed ID: 3743039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.